J Transl Med July 2023 PMID 37408030

Oral-microbiome-derived signatures enable non-invasive diagnosis of laryngeal cancers.

Shuting Yu, Junru Chen, Yan Zhao, Fangxu Yan, Yue Fan, Xin Xia, Guangliang Shan, Peng Zhang, Xingming Chen

Download social card

Mentions

Peak: 1 in Jul 2023

across 3 sources since Jul 2023

Extended reach

1,450

potential audience

Total likes

Video views

Mentions per month

Jul 2023 – Oct 2023

Where it's discussed

X / Twitter2 posts
News2 articles
YouTube1 videos

AI synopsis

What people are saying

The discussions clearly favor the publication's implications, with comments such as calling the microbiome signature a 'game-changer' and emphasizing its 'potential for early diagnosis.' The tone reflects optimism about clinical applications, though some posts are cautious or curious, which shows balanced yet engaged interest.

AgreementStrong agreement

Most discussions strongly support the idea that oral microbiome signatures could revolutionize non-invasive diagnostics for laryngeal cancers.

InterestModerate interest

While the topic is engaging, some comments suggest a cautious outlook, indicating moderate interest rather than overwhelming enthusiasm.

EngagementModerate engagement

Participants reference the methodology and potential clinical implications, showing a reasonable level of engagement.

ImpactHigh impact

Several posts highlight the significant potential impact, considering the ability to diagnose cancers non-invasively and early using microbiome analysis.

Abstract in brief

Recent research shows that the microbiota in patients with head and neck cancers, including laryngeal squamous cell carcinoma (LSCC), is significantly different from that of healthy individuals, suggesting it might influence cancer development.
Using 16S rRNA gene sequencing, scientists analyzed oral rinse and tissue samples from LSCC patients and controls, identifying specific bacterial groups associated with the cancer and developing a predictive model that can diagnose LSCC with about 85.7% accuracy.
This study is the first to demonstrate that the oral rinse microbiome could serve as a noninvasive biomarker for early diagnosis of LSCC, highlighting the potential of microbiome analysis in clinical applications.

Read the full abstract

All mentions

Oral Microbiome Signatures for Non-Invasive Laryngeal Cancer Diagnosis

Recent research indicates distinct microbiota differences in patients with head and neck cancers, including laryngeal squamous cell carcinoma. A model using oral rinse samples achieves around 85.7% accuracy in…

Medicine RTCL TV · Oct 22, 2023 12 views

ATS G&G Section

@ATS_GG · X

Oral-microbiome-derived signatures enable non-invasive diagnosis of laryngeal cancers https://t.co/0cJ8RwGZe1

Aug 8, 2023 · 1 like · 742 followers View post →

OTOdocs

@OTO_docs · X

Oral-microbiome-derived signatures enable non-invasive diagnosis of laryngeal cancers https://t.co/OUJK6JGpai

Jul 6, 2023 · 696 followers View post →